<?xml version="1.0" encoding="UTF-8"?>
<p>Liver USG or computed tomography and serum AFP levels were checked every 6 months for HCC surveillance in study subjects. Follow-up started from the end of antiviral treatment in the treatment group and after diagnosis of CHC infection in the no-treatment group and continued until date of HCC diagnosis or last follow-up.</p>
